Nottingham University Hospitals NHS Trust
196 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Cellular Pathology, City Hospitals, Hucknall Road
Nottingham NG5 1PB , United Kingdom
Nottingham NG5 1PB , United Kingdom
Accreditation
Active
UKAS
8162
nuh.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8162
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (196)
| Standard Reference | Description | Category |
|---|---|---|
| MEASUREMENT | Measurement | Electrical |
| Amyloid | Amyloid | Immunology / Serology |
| CD117 | CD117 | Immunology / Serology |
| CD79b | CD79b | Immunology / Serology |
| LAMBDA | Lambda | Immunology / Serology |
| Lymphoproliferative disorders | lymphoproliferative disorders: | HMDS-FLO-SOP-2 | Immunology / Serology |
| Acid Fast Bacilli | Acid fast bacilli | Other |
| Acid Fast Bacteria | Acid Fast Bacteria | Other |
| Acid Mucins | Acid Mucins | Other |
| Acid mucins, Neutral Mucins & | Acid mucins, Neutral Mucins & | Other |
| Activated T and B cells | Activated T and B cells | Other |
| Activated human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells | Activated human cytotoxic T lymphocytes (CTL) and natural killer (NK) cells | Other |
| Acute Leukaemia – AML, B- ALL and T-ALL | Acute Leukaemia – AML, B- ALL and T-ALL | Other |
| Adrenocorticotrophic hormone, pituitary tumours | Adrenocorticotrophic hormone, pituitary tumours | Other |
| Alpha-1-fetoprotein, classifying neoplastic liver disease and germ cell tumours | Alpha-1-fetoprotein, classifying neoplastic liver disease and germ cell tumours | Other |
| Anaplastic Large Cell | Anaplastic large cell | Other |
| Antibody labels hepatocytes and is a useful tool for the differential diagnosis of hepatocellular tumours in general | Antibody labels hepatocytes and is a useful tool for the differential diagnosis of hepatocellular tumours in general | Other |
| Aspirate morphology | Aspirate morphology | Other |
| B cell activator proteins | B cell activator proteins | Other |
| B cell specific activator protein | B cell specific activator protein | Other |
| B cells and B Cell neoplasms | B cells and B-cell neoplasms | Other |
| B cells and identification of neoplasms of B cell derivation | B cells and identification of neoplasms of B cell derivation | Other |
| Basal cell compartments of stratified and combined epithelia | Basal cell compartments of stratified and combined epithelia | Other |
| Basement Membranes | Basement membranes | Other |
| Basement membrane zone | Basement membrane zone | Other |
| Basophilic and Eosinophilic tissue structures measurement | Basophilic and eosinophilic tissue structures measurement | Other |
| CD14; CD19 | CD14; CD19 | Other |
| CD15; CD13 | CD15; CD13 | Other |
| CD1a positive cells in normal and neoplastic tissue | CD1a positive cells in normal and neoplastic tissue | Other |
| CD20; CD22 | CD20; CD22 | Other |
| CD23; CD38 | CD23; CD38 | Other |
| CD34 | CD34 | Other |
| CD34 is a useful marker for the identification of vascular and lymphatic tumours and for the sub classification of leukaemia’s measurement | CD34 is a useful marker for the identification of vascular and lymphatic tumours and for the sub classification of leukaemia’s measurement | Other |
| CD3; CD235a | CD3; CD235a | Other |
| CD43; CD45 | CD43; CD45 | Other |
| CD56; MPO | CD56; MPO | Other |
| CD5; CD10 | CD5; CD10 | Other |
| CD7; CD33 | CD7; CD33 | Other |
| CEA expressing cells | CEA expressing cells | Other |
| Calcitonin producing C cells – medullary thyroid carcinoma | Calcitonin producing C cells – medullary thyroid carcinoma | Other |
| Cells of mesenchymal origin in normal and neoplastic tissues, and is of value in tumour diagnosis | Cells of mesenchymal origin in normal and neoplastic tissues, and is of value in tumour diagnosis | Other |
| Chronic Myeloid disorders- MDS | Chronic Myeloid disorders- MDS | Other |
| Classification of B cell lymphomas, follicual lymphomas and Burkitts lymphoma measurement | Classification of B cell lymphomas, follicual lymphomas and Burkitts lymphoma measurement | Other |
| Classification of T-Cell neoplasms | Classification of T-cell neoplasms | Other |
| Classification of Wilm’s tumour, malignant mesothelioma and serous ovarian adenocarcinoma | Classification of Wilm’s tumour, malignant mesothelioma and serous ovarian adenocarcinoma | Other |
| Classification of anaplastic large cell lymphoma | Classification of anaplastic large cell lymphoma | Other |
| Classification of breast tumours | Classification of breast tumours | Other |
| Classification of ovarian sex cord and stromal tumours | Classification of ovarian sex cord and stromal tumours | Other |
| Classification of pituitary adenomas | Classification of pituitary adenomas | Other |
| Classification of precursor B- and T-cell acute lymphoblastic lymphoma/leukemia (ALL) and thymoma measurement | Classification of precursor B- and T-cell acute lymphoblastic lymphoma/leukemia (ALL) and thymoma measurement | Other |
| Classification of thymomas and malignancies of T-cell precursors measurement | Classification of thymomas and malignancies of T-cell precursors measurement | Other |
| Classification of tumours of smooth muscle | Classification of tumours of smooth muscle | Other |
| Complement C4 demonstration | Complement C4 demonstration | Other |
| Cytokeratin 7&8 on secretory epithelium – identifies tumours of epithelial origin measurement | Cytokeratin 7&8 on secretory epithelium – identifies tumours of epithelial origin measurement | Other |
| Cytokeratin – classification of tumours of epithelial origin | Cytokeratin – classification of tumours of epithelial origin | Other |
| Cytotoxic suppressor T Cells | Cytotoxic suppressor T cells | Other |
| Defects in LAMA2 cause of merosin-deficient congenital muscular dystrophy | Defects in LAMA2 cause of merosin-deficient congenital muscular dystrophy | Other |
| Demonstrate COX positivity in skeletal muscle fibres | Demonstrate COX positivity in skeletal muscle fibres | Other |
| Demonstrates glycogenoses measurement | Demonstrates glycogenoses measurement | Other |
| Detection of HPV infected cells | Detection of HPV infected cells | Other |
| Detection of HSV in human cellular material | Detection of HSV in human cellular material | Other |
| Detection of activated platelets, neutrophils and basophils | Detection of activated platelets, neutrophils and basophils | Other |
| Detection of antigens to Lamda | Detection of antigens to Lamda | Other |
| Detection of antigens to C1q | Detection of antigens to C1q | Other |
| Detection of antigens to C3 | Detection of antigens to C3 | Other |
| Detection of antigens to IgA | Detection of antigens to IgA | Other |
| Detection of antigens to IgG | Detection of antigens to IgG | Other |
| Detection of antigens to IgM | Detection of antigens to IgM | Other |
| Detection of antigens to Kappa | Detection of antigens to Kappa | Other |
| Determine HER2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens | Determine HER2 gene amplification in formalin-fixed, paraffin-embedded breast cancer tissue specimens | Other |
| Differential diagnosis of gasterointestinal stromal tumours | Differential diagnosis of gasterointestinal stromal tumours | Other |
| Differential identification of colorectal carcinoma | Differential identification of colorectal carcinoma | Other |
| Differential identification of colorectal carcinomas | Differential identification of colorectal carcinomas | Other |
| Differential identification of colorectal carcinomas measurement | Differential identification of colorectal carcinomas measurement | Other |
| Differentiated neuronal tumours | Differentiated neuronal tumours | Other |
| Differentiation and identification of epithelial tumours (1) and epithelioid hemangioendotheliomas | Differentiation and identification of epithelial tumours (1) and epithelioid hemangioendotheliomas | Other |
| Differentiation between primary mucinous ovarian cancer and colon adenocarcinoma metastatic to the ovary | Differentiation between primary mucinous ovarian cancer and colon adenocarcinoma metastatic to the ovary | Other |
| Differentiation between squamous cell carcinoma and adenocarcinoma | Differentiation between squamous cell carcinoma and adenocarcinoma | Other |
| Differentiation of neuroendocrine tumours | Differentiation of neuroendocrine tumours | Other |
| Digital slide scanning for morphological assessment and diagnosis measurement | Digital slide scanning for morphological assessment and diagnosis measurement | Other |
| Disorders- B & T | Disorders- B & T | Other |
| E-cadherin-positive cells in normal and neoplastic tissues | E-cadherin-positive cells in normal and neoplastic tissues | Other |
| Elastin/collagen/muscle/ RBC | Elastin/collagen/muscle/ RBC | Other |
| Emery-Dreifuss muscular dystrophy measurement | Emery-Dreifuss muscular dystrophy measurement | Other |
| Enzyme Histochemistry activities for the purposes of clinical diagnosis | Enzyme Histochemistry activities for the purposes of clinical diagnosis | Other |
| Epithelial tissues from simple glandular to stratified squamous epithelium and identification of normal and neoplastic cells of epithelial origin | Epithelial tissues from simple glandular to stratified squamous epithelium and identification of normal and neoplastic cells of epithelial origin | Other |
| Erythrocyte structure / actin cytoskeleton | Erythrocyte structure / actin cytoskeleton | Other |
| Ewing’s Sarcoma marker | Ewing’s Sarcoma marker | Other |
| Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis | Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis | Other |
| Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis (cont) | Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis (cont) | Other |
| Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis measurement | Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis measurement | Other |
| Examination of tissues to identify or exclude enzymatic abnormalities for the purpose of diagnosis | Examination of tissues to identify or exclude enzymatic abnormalities for the purpose of diagnosis | Other |
| Expressed in developing brain | Expressed in developing brain | Other |
| Expressed in mammary gland and several exocrine tissues | Expressed in mammary gland and several exocrine tissues | Other |
| FMC7; Kappa | FMC7; Kappa | Other |
| Ferric Iron | Ferric iron | Other |
| Fibrin,muscle,collagen,RBC | Fibrin,muscle,collagen,RBC | Other |
| Fibrinoligase, skin disorders | Fibrinoligase, skin disorders | Other |
| Follicular dendritic cells and mature B cells, lymphoma | Follicular dendritic cells and mature B cells, lymphoma | Other |
| Follicular lymphoma. Various B and T cell lymphoproliferative diseases | Follicular lymphoma. Various B and T cell lymphoproliferative diseases | Other |
| Glandular and transitional epithelial cells | Glandular and transitional epithelial cells | Other |
| Glial fibrillary acidic protein (GFAP) is the principal intermediate filament of mature astrocytes | Glial fibrillary acidic protein (GFAP) is the principal intermediate filament of mature astrocytes | Other |
| Glioma differentiation, low grade astrocytoma | Glioma differentiation, low grade astrocytoma | Other |
| Glycogen | Glycogen | Other |
| HLADr; CD64 | HLADr; CD64 | Other |
| Haematological examinations for the purpose of haematological malignancy diagnosis | Haematological examinations for the purpose of haematological malignancy diagnosis | Other |
| Hemoglobinuria (PNH) | Hemoglobinuria (PNH) | Other |
| Hep B Surface Antigen | Hep B surface antigen | Other |
| Histopathological Examination activities for the purposes of clinical diagnosis | Histopathological examination activities for the purposes of clinical diagnosis | Other |
| ID of B and T cell malignancies | ID of B and T cell malignancies | Other |
| ID of Burkitts’ lymphoma, follicular lymphoma, ALL and renal carcinoma (clear cell) | ID of Burkitts’ lymphoma, follicular lymphoma, ALL and renal carcinoma (clear cell) | Other |
| ID of desmoid tumours and colorectal cancer / adenoma | ID of desmoid tumours and colorectal cancer / adenoma | Other |
| ID of pro-, pre-, and mature B cells and in the classification of lymphomas | ID of pro-, pre-, and mature B cells and in the classification of lymphomas | Other |
| Identification and classification of AA-amyloidosis | Identification and classification of AA-amyloidosis | Other |
| Identification of B-cells in germinal centres, differentiation of lymphomas | Identification of B-cells in germinal centres, differentiation of lymphomas | Other |
| Identification of HHV, the likely aetiological agent of Kaposi’s sarcoma | Identification of HHV, the likely aetiological agent of Kaposi’s sarcoma | Other |
| Identification of NK cells, neural / neuroendocrine tissue,carcinoid | Identification of NK cells, neural / neuroendocrine tissue,carcinoid | Other |
| Identification of S100-positive neoplasms, such as malignant melanoma, Langerhans' histiocytosis, chondroblastoma and schwannoma | Identification of S100-positive neoplasms, such as malignant melanoma, Langerhans' histiocytosis, chondroblastoma and schwannoma | Other |
| Identification of alpha-1 antitrypsin accumulation in hepatocytes of A1AT deficient liver | Identification of alpha-1 antitrypsin accumulation in hepatocytes of A1AT deficient liver | Other |
| Identification of epithelial tumours, and may be useful in identifying cholangiocellular carcinomas | Identification of epithelial tumours, and may be useful in identifying cholangiocellular carcinomas | Other |
| Identification of hairy cell leukaemia and lymphomas | Identification of hairy cell leukaemia and lymphomas | Other |
| Identification of lymphatic invasion | Identification of lymphatic invasion | Other |
| Identification of mantle cell lymphomas measurement | Identification of mantle cell lymphomas measurement | Other |
| Identification of mucinous adenocarcinoma of gastrointestinal origin and intestinal metaplasia in Barrett's esophagus | Identification of mucinous adenocarcinoma of gastrointestinal origin and intestinal metaplasia in Barrett's esophagus | Other |
| Identification of p53 in normal and neoplastic tissue measurement | Identification of p53 in normal and neoplastic tissue measurement | Other |
| Identification of prostate adenocarcinoma | Identification of prostate adenocarcinoma | Other |
| Identification of senile plaques in brain / Alzheimer’s disease | Identification of senile plaques in brain / Alzheimer’s disease | Other |
| Identifies uteinizing hormone in normal and neoplastic tissue measurement | Identifies uteinizing hormone in normal and neoplastic tissue measurement | Other |
| Immunochemistry examination for the purposes of clinical diagnosis | Immunochemistry examination for the purposes of clinical diagnosis | Other |
| Immunofluorescence examination for the purposes of clinical diagnosis | Immunofluorescence examination for the purposes of clinical diagnosis | Other |
| Immunophenotyping of the following markers/antigens to diagnose the following – | Immunophenotyping of the following markers/antigens to diagnose the following – | Other |
| Inflammatory myofibroblastic tumors in lung tissue | Inflammatory myofibroblastic tumors in lung tissue | Other |
| Insulin positive cells in normal and neoplastic tissues | Insulin positive cells in normal and neoplastic tissues | Other |
| Insulin positive cells in normal and neoplastic tissues using immunohistochemical | Insulin positive cells in normal and neoplastic tissues using immunohistochemical | Other |
| Intrinsic membrane protein of erythrocytes | Intrinsic membrane protein of erythrocytes | Other |
| Ki-67 antigen in normal and neoplastic cells e.g soft-tissue sarcoma, prostatic adenocarcinoma, and breast carcinoma | Ki-67 antigen in normal and neoplastic cells e.g soft-tissue sarcoma, prostatic adenocarcinoma, and breast carcinoma | Other |
| Labels cells producing gastrin or structural gastrin analogues | Labels cells producing gastrin or structural gastrin analogues | Other |
| Labels erythroid cells at almost all stages of differentiation and is a useful tool for the ID of erythroleukaemia measurement | Labels erythroid cells at almost all stages of differentiation and is a useful tool for the ID of erythroleukaemia measurement | Other |
| Labels estrogen receptor α- positive cells and is useful in the assessment of estrogen receptor status in human breast carcinomas | Labels estrogen receptor α- positive cells and is useful in the assessment of estrogen receptor status in human breast carcinomas | Other |
| Labels follicle stimulating hormone in normal and neoplastic tissue | Labels follicle stimulating hormone in normal and neoplastic tissue | Other |
| Labels hCG-containing cells and used for the demonstration of trophoblastic elements, e.g. in germ cell tumours | Labels hCG-containing cells and used for the demonstration of trophoblastic elements, e.g. in germ cell tumours | Other |
| Labels melanocytes and identification of melanomas, and, if melanoma is ruled out, for adrenocortical carcinomas | Labels melanocytes and identification of melanomas, and, if melanoma is ruled out, for adrenocortical carcinomas | Other |
| Labels most epithelial cells, differentiation of adenocarcinoma versus malignant mesothelioma | Labels most epithelial cells, differentiation of adenocarcinoma versus malignant mesothelioma | Other |
| Labels normal T-Cells and related neoplasms and differentiation of T cell lymphomas | Labels normal T-Cells and related neoplasms and differentiation of T cell lymphomas | Other |
| Labels smooth and striated muscle cells as well as mesothelial cells, identification of rhabdomyosarcomas, leiomyomas and mesotheliomas | Labels smooth and striated muscle cells as well as mesothelial cells, identification of rhabdomyosarcomas, leiomyomas and mesotheliomas | Other |
| Ligand 1 protein in NSCLC | Ligand 1 protein in NSCLC | Other |
| Lipids | Lipids | Other |
| Low-grade B-cell lymphomas and myeloid disorders | Low-grade B-cell lymphomas and myeloid disorders | Other |
| Lung Carcinoma | Lung carcinoma | Other |
| Lymphoid restricted immunoglobulin octamer binding antibody | Lymphoid restricted immunoglobulin octamer binding antibody | Other |
| Lymphoma, Reed-Sternberg cells, Hodgkin’s | Lymphoma, Reed-Sternberg cells, Hodgkin’s | Other |
| Marker for differentiation of high grade invasive urothelial carcinoma from prostate cancer | Marker for differentiation of high grade invasive urothelial carcinoma from prostate cancer | Other |
| Marker of mast cell activation | Marker of mast cell activation | Other |
| Mature Lymphoid | Mature Lymphoid | Other |
| Melanin | Melanin | Other |
| Mesothelial cells both benign and malignant | Mesothelial cells both benign and malignant | Other |
| Mixed Mucins | Mixed Mucins | Other |
| Mononuclear phagocytes | Mononuclear phagocytes | Other |
| Morphological Assessment and Interpretation/Diagnosis | Morphological assessment and interpretation/diagnosis | Other |
| Morphological assessment and interpretation/diagnosis measurement | Morphological assessment and interpretation/diagnosis measurement | Other |
| Mucin-like glycoproteins – variety of tumours, classification of adenocarcinomas | Mucin-like glycoproteins – variety of tumours, classification of adenocarcinomas | Other |
| Mucins / glycogen | Mucins / glycogen | Other |
| Muscle, red blood cells, fibrin, connective tissue | Muscle, red blood cells, fibrin, connective tissue | Other |
| Myelin basic protein positive cells in normal and neoplastic tissues | Myelin basic protein positive cells in normal and neoplastic tissues | Other |
| Myeloperoxidase-positive cells in normal and neoplastic tissues and discrimination between lymphoid and myeloid disorders measurement | Myeloperoxidase-positive cells in normal and neoplastic tissues and discrimination between lymphoid and myeloid disorders measurement | Other |
| Neuroendocrine differentiation | Neuroendocrine differentiation | Other |
| Neuronal tumours | Neuronal tumours | Other |
| Non-Gynaecological (Diagnostic) Cytopathology | Non-Gynaecological (Diagnostic) Cytopathology | Other |
| Non-acid fast bacteria | Non-acid fast bacteria | Other |
| Normal B lymphocytes and malignant lymphomas | Normal B lymphocytes and malignant lymphomas | Other |
| Normal and abnormal gastric and intestinal epithelium, urothelium and Merkel cells | Normal and abnormal gastric and intestinal epithelium, urothelium and Merkel cells | Other |
| Normal and neoplastic mesothelial cells | Normal and neoplastic mesothelial cells | Other |
| Paroxysmal Nocturnal | Paroxysmal Nocturnal | Other |
| Peripheral blood T cells, NK cells, and all thymocytes | Peripheral blood T cells, NK cells, and all thymocytes | Other |
| Plays a key role in secretory granule-dependent cell death, and in defense against virus- infected or neoplastic cells | Plays a key role in secretory granule-dependent cell death, and in defense against virus- infected or neoplastic cells | Other |
| Pneumocystis/Fungi | Pneumocystis/Fungi | Other |
| Pneumocystis/Fungi measurement | Pneumocystis/Fungi measurement | Other |
| Positive cells in normal and neoplastic tissues | Positive cells in normal and neoplastic tissues | Other |
| Preparation and screening for detection or exclusion of pathological abnormalities | Preparation and screening for detection or exclusion of pathological abnormalities | Other |
| Prognostic indicator for breast cancer | Prognostic indicator for breast cancer | Other |
| Reticulin Fibres | Reticulin fibres | Other |
| Reticulin fibres (collagen) measurement | Reticulin fibres (collagen) measurement | Other |
| Routine staining for identification of basophilic and eosinophilic structures measurement | Routine staining for identification of basophilic and eosinophilic structures measurement | Other |
| Serves as a reserve supply of oxygen within muscles | Serves as a reserve supply of oxygen within muscles | Other |
| Skeletal muscle – classification of rhabdosarcomas / Wilms tumour | Skeletal muscle – classification of rhabdosarcomas / Wilms tumour | Other |
| Smooth Muscle Cells | Smooth Muscle Cells | Other |
| Smooth muscle cells, myofibroblasts and myoepithelial cells, and leiomyosarcomas and pleomorphic adenomas | Smooth muscle cells, myofibroblasts and myoepithelial cells, and leiomyosarcomas and pleomorphic adenomas | Other |
| Staining for the purposes of: Acid mucins | Staining for the purposes of: Cell differentiation | Other |
| T Cells, oligodendromas and neuroendocrine tumours | T Cells, oligodendromas and neuroendocrine tumours | Other |
| T and B cells, monocytes, granulocytes, erythrocytes, epithelial cells and mast cells | T and B cells, monocytes, granulocytes, erythrocytes, epithelial cells and mast cells | Other |
| Terminally differentiated plasma cells | Terminally differentiated plasma cells | Other |
| Thymocytes and T helper cells – identifying anaplastic T-Cell lymphoma | Thymocytes and T helper cells – identifying anaplastic T-Cell lymphoma | Other |
| Thyroid transcription factor-1 in normal and malignant cells | Thyroid transcription factor-1 in normal and malignant cells | Other |
| Transmembrane tyrosine kinase receptors measurement | Transmembrane tyrosine kinase receptors measurement | Other |
| Tumour Suppressor Gene | Tumour suppressor gene | Other |
| Tumour marker – pancreatic adenocarcinoma | Tumour marker – pancreatic adenocarcinoma | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.